SCHEMBL597229

SCHEMBL597229

N[C@@H](Cc1ccc(OC(=O)[C@@H](N)Cc2c[nH]c3ccccc23)cc1)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.71
KDM4E B2RXH2 3/20 0.71
MAPT P10636 3/20 0.71
MEN1 O00255 2/20 0.71
LMNA P02545 2/20 0.71
TSHR P16473 2/20 0.71
BLM P54132 2/20 0.71
PMP22 Q01453 2/20 0.71
MPO P05164 1/20 0.71
HIF1A Q16665 1/20 0.71
HSP90AA1 P07900 1/20 0.59
HSP90AB1 P08238 1/20 0.59
LTA4H P09960 1/20 0.59
PLA2G2A P14555 1/20 0.59
TACR1 P25103 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.52
APAF1 O14727 1/20 0.51
POLB P06746 1/20 0.51
RECQL P46063 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6032937 1.00 KMT2A (0.71) KMT2AKDM4EMAPTMEN1LMNA
Phenylalanine SCHEMBL10381280 0.99 KMT2A (0.70) KMT2AKDM4EMAPTMEN1LMNA
Pyruvate SCHEMBL17262430 0.95 KMT2A (0.64) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL28205631 0.94 KMT2A (0.65) KMT2AKDM4EMAPTMEN1LMNA
SCHEMBL1239230 0.92 MEN1 (0.59) KMT2AKDM4EMAPTMEN1LMNA
Phenylalanine SCHEMBL10623655 0.91 KMT2A (0.58) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL2689669 0.90 KMT2A (0.57) KMT2AKDM4EMAPTMEN1LMNA
Histidine SCHEMBL1996749 0.90 KMT2A (0.57) KMT2AKDM4EMAPTMEN1LMNA
SCHEMBL7775133 0.90 KDM4E (0.71) KMT2AKDM4EMAPTMEN1LMNA
SCHEMBL1401159 0.90 KDM4E (0.71) KMT2AKDM4EMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024007778-A1 USE OF PLASMA MOLECULAR MARKER KYNURENINE IN DETECTION OF EARLY HEART FAILURE 上海交通大学医学院附属上海儿童医学中心 2024-01-11 WO claimed
CN-115327129-A Application of plasma molecular marker kynurenine in early heart failure detection 上海交通大学医学院附属上海儿童医学中心 2022-11-11 CN claimed
EP-3177669-B1 AMPHIPHILIC BLOCKCOPOLYMERS COMPRISING REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES DSM IP ASSETS BV (NL) 2021-03-17 EP claimed
EP-3177669-A1 AMPHIPHILIC BLOCKCOPOLYMERS COMPRISING REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES DSM IP Assets B.V. (NL) 2017-06-14 EP claimed
WO-2016020547-A1 AMPHIPHILIC BLOCKCOPOLYMERS COMPRISING REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES DSM IP ASSETS B.V. (NL) 2016-02-11 WO claimed
US-6232293-B1 ADMINISTERING TRYPTOPHAN-TRYPTOPHAN, TRYPTOPHAN-TYROSINE, OR TYROSINE-TRYPTOPHAN DIPEPTIDE COUPLED TO PROTEIN OR PEPTIDE CARRIER AS ANTIINFLAMMATORY AGENT ANDERSON BYRON E (US) 2001-05-15 US claimed
US-5977076-A CARRIER COUPLED TO DIPETIDE; ANTIINFLAMMATORY AGENTS; GRAFTING TISSUE ANDERSON BYRON E (US) 1999-11-02 US claimed
WO-1998046248-A1 METHOD AND MATERIAL FOR INHIBITING COMPLEMENT ANDERSON BYRON E (US) 1998-10-22 WO claimed
EP-0313380-B1 Synthetic melanin aggregates ADVANCED POLYMER SYSTEMS INC (US) 1993-12-29 EP claimed
EP-0290269-A2 Immunoassay methods and reagents and methods for producing the latter CYBERFLUOR INC. (CA) 1988-11-09 EP claimed
US-20240122219-A1 COMPOSITION FOR ENHANCING UMAMI COMPRISING TYROSINE-AMINO ACID PEPTIDE AND USE THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) 2024-04-18 US disclosed
US-20240050513-A1 COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING DISEASE CAUSED BY PROTEIN NITRATION COMPRISING PEPTIDE WITH TERMINAL TYROSINE AS EFFECTIVE COMPONENT INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) 2024-02-15 US disclosed
WO-2024007778-A1 USE OF PLASMA MOLECULAR MARKER KYNURENINE IN DETECTION OF EARLY HEART FAILURE 上海交通大学医学院附属上海儿童医学中心 2024-01-11 WO disclosed
EP-4298924-A1 COMPOSITION, FOR PREVENTING, RELIEVING, OR TREATING DISEASE CAUSED BY NITRATION OF PROTEIN, CONTAINING PEPTIDE HAVING TYROSINE LOCATED AT TERMINAL AS ACTIVE INGREDIENT Industry-Academic Cooperation Foundation Gyeongsang National University (KR) 2024-01-03 EP disclosed
US-20230416772-A1 FLOE1-MEDIATED MODULATION OF SEED LONGEVITY AND GERMINATION RATES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2023-12-28 US disclosed
EP-0406557-A2 Multivalent repressor of gene function SANDOZ LTD. (CH) 1991-01-09 EP disclosed
WO-1990014427-A2 MULTIVALENT REPRESSOR OF GENE FUNCTION SANDOZ LTD (CH) 1990-11-29 WO disclosed
US-4681852-A MUTANT ESCHERICHIA COLI, PHENYLALANINE AUSTGEN-BIOJET INTERNATIONAL PTY, LTD. (AU) 1987-07-21 US disclosed
US-4638045-A CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE LIGANDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1987-01-20 US disclosed
EP-0010830-A2 Dehydropeptides Research Corporation (US) 1980-05-14 EP disclosed